Publicacións en colaboración con investigadores/as de Uppsala University (13)

2022

  1. Clinical utility and prognostic implications of the novel 4S-AF scheme to characterize and evaluate patients with atrial fibrillation: a report from ESC-EHRA EORP-AF Long-Term General Registry

    Europace, Vol. 24, Núm. 5, pp. 721-728

  2. Impact of renal impairment on atrial fibrillation: ESC-EHRA EORP-AF Long-Term General Registry

    European Journal of Clinical Investigation, Vol. 52, Núm. 6

2021

  1. Randomized evaluation of beta blocker and ACE-inhibitor/angiotensin receptor blocker treatment in patients with myocardial infarction with non-obstructive coronary arteries (MINOCA-BAT): Rationale and design: MINOCA-BAT: Rationale and design

    American Heart Journal, Vol. 231, pp. 96-104

2020

  1. Initial invasive or conservative strategy for stable coronary disease

    New England Journal of Medicine, Vol. 382, Núm. 15, pp. 1395-1407

  2. Levosimendan Efficacy and Safety: 20 Years of SIMDAX in Clinical Use

    Journal of cardiovascular pharmacology, Vol. 76, Núm. 1, pp. 4-22

  3. Levosimendan Efficacy and Safety: 20 years of SIMDAX in Clinical Use

    Cardiac Failure Review, Vol. 6

2019

  1. Design and rationale of the Management of High Bleeding Risk Patients Post Bioresorbable Polymer Coated Stent Implantation With an Abbreviated Versus Standard DAPT Regimen (MASTER DAPT) Study

    American Heart Journal, Vol. 209, pp. 97-105

2016

  1. ESC 2015 guidelines for the treatment of patients with ventricular arrhythmias and prevention of sudden cardiac death

    Revista Espanola de Cardiologia, Vol. 69, Núm. 2, pp. 176e1-176e7

  2. Ranolazine in patients with incomplete revascularisation after percutaneous coronary intervention (RIVER-PCI): A multicentre, randomised, double-blind, placebo-controlled trial

    The Lancet, Vol. 387, Núm. 10014, pp. 136-145

2015

  1. 2015 ESC Guidelines for the management of patients with ventricular arrhythmias and the prevention of sudden cardiac death the Task Force for the Management of Patients with Ventricular Arrhythmias and the Prevention of Sudden Cardiac Death of the European Society of Cardiology (ESC) Endorsed by: Association for European Paediatric and Congenital Cardiology (AEPC)

    European Heart Journal, Vol. 36, Núm. 41, pp. 2793-2867l

  2. 2015 ESC Guidelines for the management of patients with ventricular arrhythmias and the prevention of sudden cardiac death: The Task Force for the Management of Patients with Ventricular Arrhythmias and the Prevention of Sudden Cardiac Death of the European Society of Cardiology (ESC)

    Europace, Vol. 17, Núm. 11, pp. 1601-1687

  3. Wytyczne ESC dotyczące postępowania u pacjentów z komorowymi zaburzeniami rytmu oraz zapobiegania nagłym zgonom sercowym w 2015 roku

    Kardiologia Polska, Vol. 73, Núm. 10, pp. 795-900

2013

  1. Treatment, outcomes, costs, and quality of life of women and men with acute coronary syndromes who have undergone Percutaneous coronary intervention: Results from the Antiplatelet Therapy Observational Registry

    Postgraduate Medicine, Vol. 125, Núm. 2, pp. 100-107